The first showed that the P2RX7 antagonist, AZ10606120, efficiently inhibited the growth of malignant pleural mesothelioma cell lines of patients, when the tumor cell lines were implanted in immunodeficient mice [66]. Here, P2RX7 is linked to neoplasm.